Jeffrey Kindler on blockbuster drugs, share prices and the FDA

Part 2, October 28 2008: Jeffrey Kindler, chairman and CEO of Pfizer, talks to Chrystia Freeland, US managing editor, about why the era of blockbuster drugs is over, the fall in equity prices and strengthening the Food and Drug Administration. Next week, David Boies of Boies, Schiller & Flexner. If you have a question for David Boies, please email it to the link below.